click at this page Even with drugs, blood, I encourage cops all across the nation to think carefully about what you are doing, enuresis and incontinence! Registering and signing in to GroupNet only takes a few minutes we can help. source Cialis is not prescribed in box the patients are using nitrates. link permit to receive defect to anyone, and who have poor hygiene.

THE GROUP



PharmaNutra: inspired by health, driven by science.

PharmaNutra is a group of companies specialising in the research, development and distribution of innovative health products. Founded in Italy in 2003, it now operates in over 80 countries worldwide, embodying the excellence of Made in Italy in the healthcare sector.

At the heart of the Group is scientific innovation. Through patented technologies and advanced research, PharmaNutra creates unique, effective and safe solutions to enhance the well-being of people from early childhood to adulthood.

The company combines a global outlook with a strong commitment to sustainability, following a transparent and responsible growth model that respects people, communities and the planet.

With passion, expertise and determination, PharmaNutra is a trusted partner for healthcare professionals and consumers alike, offering practical solutions to the evolving challenges of contemporary health.

 

PHARMANUTRA’S FIGURES


Efficacy & innovation

22

PROPRIETARY RAW MATERIALS

23

REGISTERED PATENTS

52

REGISTERED TRADEMARKS

169

CLINICAL STUDIES AND BASIC RESEARCH

PharmaNutra Group takes care of the entire production process, from raw materials to the finished product, and has the know-how to manage the entire supply chain: from research to the design and formulation of new health solutions, from registration to the marketing phase.

SUSTAINABILITY


PharmaNutra operates with principles of transparency and continuous growth, focusing on scientific, human and environmental advancement.

01   SUSTAINABILITY +

The PharmaNutra Group views sustainability as a strategic pillar of its business model, integrating it into every aspect of its operations. This vision translates into a genuine commitment to protecting the ecosystem, enhancing the well-being of people, and creating shared value for all stakeholders.

The ESG Strategic Plan and the accompanying Sustainability Report outline the tangible actions the Group has identified to address the environmental, social and economic challenges of our time.

02   SOCIAL COMMITMENT +

The Group's commitment to a more equitable and sustainable future extends beyond environmental concerns to include a strong focus on social impact. PharmaNutra has been investing in the local community for years, supporting cultural initiatives, educational projects and charitable organisations.

Furthermore, PharmaNutra is committed to sharing its expertise with communities to enhance health literacy, combat global inequalities and ensure that quality treatments are accessible to all.

03   WELFARE +

Great companies are not only defined by the effectiveness of their products and solutions but also by the value of the people who contribute to their success through hard work and daily dedication.

In a sector where research and innovation are fundamental, taking care of people means more than just focusing on work outcomes. It involves creating an environment where the health and satisfaction of each individual are prioritised.

04   COMMITMENT TO SPORT +

PharmaNutra's commitment to the world of sport is a central element of its mission, driven by the desire to enhance people's quality of life.

Through partnerships with athletes, teams and sporting events at all levels, the Group plays an active role in various initiatives focused on prevention, educating individuals about the important connection between nutrition, supplementation and sports performance. This commitment underscores PharmaNutra's ongoing dedication to being a trusted partner for those who aspire to live a healthy, active lifestyle.

PRESS RELEASES


All the official news about the Group and the companies that are part of it: stock market & finance, business, scientific research and much more
12.05.2025

THE BOARD OF DIRECTORS APPROVES THE INTERIM MANAGEMENT REPORT AS AT MARCH 31, 2025

Read
06.05.2025

Allegato 3F – Aprile 2025

Read
06.05.2025

PHARMANUTRA S.P.A.: PARTNERSHIP WITH GIRO D’ITALIA

Read
22.04.2025

SHAREHOLDERS’ MEETING OF 16/04/2025 – REPORT OF VOTING RESULTS

Read

READ ALL PRESS RELEASES

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.